Loading…
The company received a patent for its innovative medical device.
Autonomix Medical, Inc. (Nasdaq: AMIX) announced on August 25, 2026, that it has been granted a patent by the relevant authorities. This patent pertains to the company's innovative medical device designed to improve patient outcomes.
The granted patent solidifies Autonomix Medical's intellectual property portfolio, enhancing its competitive position in the medical device industry. The company continues to focus on developing cutting-edge solutions for healthcare providers.
As of the latest available data, Autonomix Medical has a free float of 526,438 shares and 971,043 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.